Martin J Cannon Selected Research

Martin J Cannon Research Topics

Disease

31	Neoplasms (Cancer) 01/2022 - 02/2002
20	Ovarian Neoplasms (Ovarian Cancer) 11/2023 - 02/2002
10	Uterine Cervical Neoplasms (Cancer of the Cervix) 02/2008 - 05/2003
6	Carcinoma (Carcinomatosis) 02/2009 - 01/2004
3	Ascites 12/2017 - 06/2004
3	Breast Neoplasms (Breast Cancer) 08/2012 - 06/2003
3	Endometrial Neoplasms (Endometrial Cancer) 07/2005 - 08/2004
2	Liver Neoplasms (Liver Cancer) 01/2023 - 01/2022
2	Infections 12/2019 - 01/2005
2	Ovarian Epithelial Carcinoma 01/2017 - 02/2009
2	Testicular Neoplasms (Testicular Cancer) 01/2012 - 07/2011
2	Papillary Carcinoma 07/2005 - 10/2004
1	Rubella (German Measles) 01/2022
1	Colorectal Neoplasms (Colorectal Cancer) 01/2022
1	Mumps 01/2022
1	Measles 01/2022
1	Melanoma (Melanoma, Malignant) 12/2019
1	Lewis Lung Carcinoma 12/2019
1	Dysbiosis 12/2019
1	Carcinosarcoma 08/2012
1	Stomach Neoplasms (Stomach Cancer) 08/2012
1	Prostatic Neoplasms (Prostate Cancer) 01/2012
1	Multiple Myeloma 07/2011
1	Hypersensitivity (Allergy) 03/2006
1	Endometrioid Carcinoma 07/2005

Drug/Important Bio-Agent (IBA)

13	AntigensIBA 10/2020 - 02/2002
6	VaccinesIBA 11/2023 - 01/2005
6	Proteins (Proteins, Gene)FDA Link 07/2011 - 01/2005
5	EnzymesIBA 02/2009 - 01/2004
4	CytokinesIBA 12/2019 - 06/2003
4	Neoplasm Antigens (Tumor Antigens)IBA 04/2014 - 06/2003
4	EpitopesIBA 02/2009 - 05/2005
4	Peptides (Polypeptides)IBA 02/2009 - 05/2005
4	Oncogene Proteins (Oncogene Protein)IBA 10/2007 - 05/2003
4	ParaffinIBA 03/2005 - 01/2004
3	Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA 05/2015 - 04/2011
3	Trastuzumab (Herceptin)FDA Link 08/2012 - 05/2002
3	Serine Proteases (Serine Protease)IBA 02/2009 - 01/2004
2	Interleukin-10 (Interleukin 10)IBA 12/2017 - 04/2014
2	Monoclonal AntibodiesIBA 08/2012 - 02/2004
2	ImmunosorbentsIBA 02/2009 - 07/2005
2	Interferon-gamma (Interferon, gamma)IBA 02/2009 - 01/2009
2	Interleukin-2 (IL2)IBA 03/2006 - 08/2003
2	Claudin-3IBA 05/2005 - 10/2004
2	Claudin-4IBA 05/2005 - 10/2004
2	Epidermal Growth Factor (EGF)IBA 03/2005 - 08/2004
2	Formaldehyde (Formol)FDA Link 01/2005 - 10/2004
2	OligonucleotidesIBA 01/2005 - 10/2004
2	Peptide Hydrolases (Proteases)FDA Link 10/2004 - 01/2004
1	Immune Checkpoint InhibitorsIBA 11/2023
1	Granzymes (Granzyme)IBA 01/2022
1	Measles-Mumps-Rubella Vaccine (MMR Vaccine)IBA 01/2022
1	Anti-Bacterial Agents (Antibiotics)IBA 12/2019
1	Lymphocyte Function-Associated Antigen-1 (LFA-1)IBA 12/2019
1	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 12/2019
1	Amyloid Precursor Protein Secretases (beta-Secretase)IBA 01/2017
1	Polysaccharides (Glycans)IBA 01/2017
1	GlycosyltransferasesIBA 01/2017
1	CateninsIBA 05/2015
1	Galectin 3 (LGALS3)IBA 12/2014
1	Cancer VaccinesIBA 04/2014
1	human ROPN1 proteinIBA 07/2011
1	AutoantigensIBA 06/2009
1	TADG-12 serine proteaseIBA 02/2009
1	HLA Antigens (Human Leukocyte Antigens)IBA 01/2009
1	keyhole-limpet hemocyanin (keyhole limpet hemocyanin)IBA 02/2008
1	HLA-B57 antigenIBA 06/2006
1	ChromiumIBA 06/2006
1	Interleukin-6 (Interleukin 6)IBA 07/2005
1	Cytotoxins (Cytolysins)IBA 07/2005
1	Clostridium enterotoxinIBA 05/2005
1	Tight Junction ProteinsIBA 05/2005
1	Indicators and Reagents (Reagents)IBA 03/2005
1	poliovirus receptorIBA 01/2005
1	Papillomavirus Vaccines (HPV Vaccines)IBA 01/2005
1	1-oleoyl-2-stearoylphosphatidylcholineIBA 10/2004
1	CalciumIBA 10/2004
1	Epithelial Cell Adhesion MoleculeIBA 10/2004
1	Lipocalin-2IBA 10/2004
1	matriptaseIBA 10/2004
1	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 10/2004
1	Transforming Growth Factor beta Receptors (TGF beta Receptors)IBA 10/2004
1	thrombospondin 2IBA 10/2004
1	OsteopontinIBA 10/2004
1	Kallikreins (Kallikrein)IBA 10/2004
1	Laminin (Merosin)IBA 10/2004
1	Carboplatin (JM8)FDA LinkGeneric 08/2004
1	Cisplatin (Platino)FDA LinkGeneric 08/2004
1	Doxorubicin (Adriamycin)FDA LinkGeneric 08/2004
1	Paclitaxel (Taxol)FDA LinkGeneric 08/2004
1	Sialic AcidsIBA 06/2004
1	3-methyl-N,N-diethyl-p-phenylenediamineIBA 06/2004
1	LipidsIBA 06/2004

Therapy/Procedure

19	Immunotherapy 01/2022 - 02/2002
10	Therapeutics 12/2014 - 05/2002
9	Drug Therapy (Chemotherapy) 08/2012 - 05/2002
3	Radiotherapy 10/2007 - 08/2004
1	Oncolytic Virotherapy 01/2023
1	Subcutaneous Injections 02/2008
1	Intradermal Injections 03/2006